Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Letters

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.canlet.2009.10.004PMID 19900758PMCID PMC3099213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory Pathways in Liver Homeostasis and Liver Injury

  2009cited by this paper
• Multitargeted therapy of cancer by silymarin.

  2008cited by this paper
• Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation.

  2008cited by this paper
• CYP2E1 and oxidative liver injury by alcohol.

  2008cited by this paper
• Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.

  2008cited by this paper
• Oxidative mechanisms in the pathogenesis of alcoholic liver disease.

  2008cited by this paper
• The Activity of Class I, II, III, and IV Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) in Liver Cancer

  2008influential reference
• An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin

  2008cited by this paper
• Cell cycle control as a basis for cancer chemoprevention through dietary agents.

  2008cited by this paper
• S‐Adenosylmethionine in cell growth, apoptosis and liver cancer

  2008cited by this paper
• Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

  2007cited by this paper
• Silybin and silymarin--new and emerging applications in medicine.

  2007cited by this paper
• Effects and mechanisms of silibinin on human hepatoma cell lines.

  2007cited by this paper
• Alcohol-induced disruption of endocrine signaling.

  2007cited by this paper
• Acetaldehyde generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculations on the role of other enzymes and processes.

  2007cited by this paper
• Carcinogenicity of alcoholic beverages.

  2007cited by this paper
• Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application.

  2007cited by this paper
• Alcohol Metabolism and Cancer Risk

  2007influential reference
• Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Alcohol and liver cancer.

  2007influential reference
• Role of S‐adenosyl‐L‐methionine in liver health and injury

  2007cited by this paper
• S-ADENOSYL-L-METHIONINE ATTENUATES OXIDATIVE STRESS AND HEPATIC STELLATE CELL ACTIVATION IN AN ETHANOL-LPS-INDUCED FIBROTIC RAT MODEL

  2007cited by this paper
• Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma.

  2007cited by this paper
• Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.

  2007cited by this paper
• Hepatocellular carcinoma pathogenesis: from genes to environment

  2006cited by this paper
• Microencapsulation of Engineered Cells to Deliver Sustained High Circulating Levels of Interleukin-6 to Study Hepatocellular Carcinoma Progression

  2006cited by this paper
• S-adenosyl-L-methionine for alcoholic liver diseases.

  2006cited by this paper
• Mitochondrial glutathione: Hepatocellular survival–death switch

  2006cited by this paper
• Molecular pathogenesis of hepatocellular carcinoma.

  2006cited by this paper
• Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?

  2005cited by this paper
• Alcohol and liver cancer.

  2005cited by this paper
• A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).

  2005cited by this paper
• Silibinin Efficacy against Human Hepatocellular Carcinoma

  2005cited by this paper
• Herbal Medicines for Liver Diseases

  2005cited by this paper
• Recent advances in alcohol-induced adduct formation.

  2005cited by this paper
• Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.

  2004cited by this paper
• A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.

  2004cited by this paper
• Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor α (ERα)and ERβ in Human Cells

  2004cited by this paper
• Silymarin is a selective estrogen receptor β (ERβ) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats

  2003cited by this paper
• Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats.

  2003cited by this paper
• Influence of Alcohol and Gender on Immune Response

  2002cited by this paper
• Assessing bioflavonoids as regulators of NF-kappa B activity and inflammatory gene expression in mammalian cells.

  2001cited by this paper
• Inhibition of alcohol dehydrogenase blocks enhanced Gi-protein expression following ethanol treatment in experimental hepatocellular carcinoma in vitro

  2001cited by this paper
• Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.

  1999cited by this paper
• Altered expression of mitogen‐activated protein kinases in a rat model of experimental hepatocellular carcinoma

  1997cited by this paper
• Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2E1.

  1994cited by this paper
• Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes.

  1994cited by this paper
• Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a.

  1986cited by this paper

• Effects of soluble epoxide hydrolase inhibition on liver injury and gut microbiota in mice chronically fed ethanol.

  2025cites this paper
• Protective effects of Pleurotus placentodes against liver injury in mice via the PTGS2, NR3C1 and PPARA signaling pathways

  2024cites this paper
• Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders

  2024cites this paper
• Silybum marianum, antioxidant activity, and cancer patients

  2021cites this paper
• Ellagic Acid Prevents Binge Alcohol-Induced Leaky Gut and Liver Injury through Inhibiting Gut Dysbiosis and Oxidative Stress

  2021cites this paper
• New insight and potential therapy for NAFLD: CYP2E1 and flavonoids.

  2021cites this paper
• Changes in Glutathione Content in Liver Diseases: An Update

  2021cites this paper
• Flavonoids-mediated SIRT1 signaling activation in hepatic disorders.

  2020cites this paper
• Phytochemicals in the Prevention of Ethanol-Induced Hepatotoxicity

  2019cites this paper
• Altered fatty acid‐binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma

  2018cites this paper
• Use of a crossed high alcohol preferring (cHAP) mouse model with the NIAAA-model of chronic-binge ethanol intake to study liver injury

  2017cites this paper
• Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance

  2017cites this paper
• Ergebnisse universitärer Forschung in der Naturheilkunde: Klinische Phytotherapie

  2017cites this paper
• Acrylamide induces HepG2 cell proliferation through upregulation of miR-21 expression

  2017cites this paper
• Silibinin: a potential old drug for cancer therapy

  2016cites this paper
• Production of Healthy Fermented Milk Supplemented with Natural Sources of Antioxidants

  2016cites this paper
• Providing scientific evidence for the use of dietary supplements: a case study in hepatoprotective plants

  2016cites this paper
• Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma

  2016cites this paper
• Silibinin Prevents Autophagic Cell Death upon Oxidative Stress in Cortical Neurons and Cerebral Ischemia-Reperfusion Injury

  2016cites this paper
• Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review.

  2016cites this paper
• Role of alcohol in the development and progression of hepatocellular carcinoma.

  2016cites this paper
• A Promising CAM Therapeutic For Multiple Cancers: Milk Thistle (Silybum)

  2015cites this paper
• The effect of alcohol on Sirt1 expression and function in animal and human models of hepatocellular carcinoma (HCC).

  2015cites this paper
• Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review

  2015cites this paper
• Can Phytochemicals be Effective in Preventing Ethanol-Induced Hepatotoxicity in the Geriatric Population? An Evidence-Based Revisit

  2015cites this paper
• Behavioral and Neurochemical Deficits in Aging Rats with Increased Neonatal Iron Intake: Silibinin’s Neuroprotection by Maintaining Redox Balance

  2015cites this paper
• Oxidative Stress in Fetal Alcohol Spectrum Disorders – Insights for the Development of Antioxidant-Based Therapies

  2014cites this paper
• Curcumin and (-)-epigallocatechin-3-gallate attenuate acrylamide-induced proliferation in HepG2 cells.

  2014cites this paper
• Phytochemicals Are Effective in the Prevention of Ethanol-Induced Hepatotoxicity

  2013cites this paper
• Antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity of artichoke, milk thistle and borututu

  2013cites this paper
• Silimarina, ácido alfa-lipoico y seleniometionina en el tratamiento de hígado graso: revisión sistemática de la literatura

  2013cites this paper
• Biotransformation of silybin and its congeners.

  2013cites this paper
• New Therapeutic Potentials of Milk Thistle (Silybum marianum)

  2013cites this paper
• Inflammation and MMPs in alcohol-induced liver diseases and protective action of antioxidants.

  2013cites this paper
• PhARMACOLOgY OF SILYBUM MARIANUM ANd ITS ACTIvE CONSTITUENTS . ThERAPEUTIC ACTIvITY – PART 1

  2012cites this paper
• Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.

  2012cites this paper
• Silymarin in the prevention and treatment of liver diseases and primary liver cancer.

  2012cites this paper
• Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model

  2012cites this paper
• Evaluation of a bioresorbable drug delivery system for the treatment of hepatocellular carcinoma.

  2012cites this paper
• Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice.

  2012cites this paper
• Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI

  2012cites this paper
• NPC Natural Product Communications

  2011cites this paper
• Alcohol induces liver neoplasia in a novel alcohol-preferring rat model.

  2011cites this paper
• Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma.

  2011cites this paper
• Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation

  2011cites this paper
• An Overview of Anticancer Herbal Medicines

  2011cites this paper
• Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non‐hepatitis B virus/non‐hepatitis C virus‐related hepatocellular carcinoma

  2011cites this paper
• Silibinin: a novel inhibitor of Aβ aggregation.

  2011cites this paper
• Activated Protein C Restores Hepatic Microcirculation During Sepsis by Modulating Vasoregulator Expression

  2011cites this paper
• Targeting collagen expression in alcoholic liver disease.

  2011cites this paper
• Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer

  2010cites this paper
• Phytomedicine : Silybum marianum ( Silymarin ) as an Effective Hepato-protective Source from Nature

  year unknowncites this paper